Carlsmed, Inc. (CARL) Stock Statistics & Valuation Metrics

Carlsmed, Inc. has a market cap or net worth of $352.62M. The enterprise value is $258.10M.

Carlsmed, Inc. has 26,592,909 shares outstanding. The number of shares has decreased by -2.65% in one year.

Carlsmed, Inc.’s return on equity (ROE) is 0.34 and return on invested capital (ROIC) is -54.94%.

The current PE Ratio of Carlsmed, Inc. is ―. Carlsmed, Inc.’s PEG ratio is 0.15.

In the last 12 months, Carlsmed, Inc. had revenue of 27.16M and earned -24.26M in profits. Earnings per share was -1.50.

In the last 12 months, operating cash flow was -27.86M and capital expenditures -1.19M, giving a free cash flow of -29.05M billion.

Carlsmed, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―

Carlsmed, Inc. upcoming earnings date is Feb 19, 2026, After Close (Confirmed).

Carlsmed, Inc. as a current ratio of 5.60, with Debt / Equity ratio of 16.51%

In the past 12 months, Carlsmed, Inc. has paid 0.00 in taxes.

Carlsmed, Inc. EV to EBITDA ratio is -9.53, with an EV/FCF ratio of -8.47.

Carlsmed, Inc. has $115.37M in cash and marketable securities with $17.61M in debt, giving a net cash position of $97.76M billion.

Gross margin is 74.76%, with operating margin of -88.80%, and net profit margin of -89.30%.

The average price target for Carlsmed, Inc. is $20.25, which is 11.43% higher than the current price. The consensus rating is Strong Buy